 |
This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (July 2009) |
Valproate semisodium (INN) or divalproex sodium (USAN) consists of a compound of sodium valproate and valproic acid in a 1:1 molar relationship in an enteric coated form. It is used in the UK, Canada, and U.S. for the treatment of the manic episodes of bipolar disorder. In rare cases, it is also used as a treatment for major depressive disorder, and increasingly taken long-term for prevention of both manic and depressive phases of bipolar disorder, especially the rapid-cycling variant. It is also used in the US for the treatment of epilepsy, chronic pain associated with neuropathy, and migraine headaches. Its chemical name is sodium hydrogen bis(2-propylpentanoate). The extended release formulation allows for a single daily dose.
In the UK semisodium valproate has been sold for a few years as the proprietary drug Depakote and marketed for psychiatric conditions only. It is about five times the price of sodium valproate, which has been marketed for around 30 years as Epilim by the same company for epilepsy and is also available from other manufacturers as a generic product.
Contents |
Side effects
The most severe side effects are ten times higher-than-average incidence rates of serious, irreversible birth defects (teratogenic) such as births of brainless babies (anencephaly). People who take this drug can experience a variety of side effects, some of which may require immediate medical attention. Especially dangerous side effects include vomiting, loss of appetite, fever, or dark urine. These suggest a possibility of liver damage. People taking this drug should also call their doctor if they experience other serious side effects. Some serious side effects are unusual bleeding (especially in the urine), hallucinations, and complete drowsiness. Some people also experience constipation or diarrhea from use of this drug. 1% to 10% of people report weight gain and increased appetite. The same percentage also reports abnormal dreams. [1] Major risk of birth defects such as spina bifida has been demonstrated among populations of female patients who took the medicine in childbearing age.
Branded formulations
- Brazil—Depakote by Abbott Laboratories
- Canada—Epival by Abbott Laboratories.
- Mexico—Epival and Epival ER (Extended Release) by Abbott Laboratories.
- United Kingdom—Depakote by Sanofi-Aventis
- United States—Depakote and Depakote ER (Extended Release) by Abbott Laboratories
- India— Valance by Piramal
- Germany— Ergenyl Chrono by Sanofi-Aventis and generics
- France and other European countries — Dépakine Chrono and generics
Other- Brand names for this medication Depacon, Depakene, Depakote, Depakote ER, Zalkote. [1]
In the US, generic versions of brand-name Depakote became available on July 29, 2008.[2].
India Depakote XR now available with Sanofi-aventis and Rex xr with abbott laboratories
References
- ^ Drug Information Handbook, 15th ed.
- ^ http://fdanews.com/newsletter/article?issueId=11836&articleId=109236
External links
- RXList.com: Depakote (Divalproex sodium)
- British National Formulary Edition 50
- Drugs.com Advanced Consumer Info: Valproic Acid
- Depakote (Official) - Abbott Laboratories
- Drug Information Online
- [2]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
